Violaine Giraud

9 Avenue Charles De Gaulle
Boulogne-billancourt, 92100, France

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 25 publications

Role of the HGF/c-MET pathway in resistance to immune checkpoint inhibitors in advanced non-small cell lung cancer.

Role of the HGF/c-MET pathway in resistance to immune checkpoint inhibitors in advanced non-small cell lung cancer.

Journal: Cancer immunology, immunotherapy : CII

Published: September 05, 2024

Respiratory recovery trajectories after severe-to-critical COVID-19: a 1-year prospective multicentre study.

Respiratory recovery trajectories after severe-to-critical COVID-19: a 1-year prospective multicentre study.

Journal: The European respiratory journal

Published: August 03, 2022

Gene expression profile of high PD-L1 non-small cell lung cancers refractory to pembrolizumab.

Gene expression profile of high PD-L1 non-small cell lung cancers refractory to pembrolizumab.

Journal: Cancer immunology, immunotherapy : CII

Published: February 28, 2022

Gender Differences in Idiopathic Pulmonary Fibrosis: Are Men and Women Equal?

Gender Differences in Idiopathic Pulmonary Fibrosis: Are Men and Women Equal?

Journal: Frontiers in medicine

Published: May 23, 2021

Low income and outcome in idiopathic pulmonary fibrosis: An association to uncover.

Low income and outcome in idiopathic pulmonary fibrosis: An association to uncover.

Journal: Respiratory medicine

Published: February 03, 2021

Plasma Biomarkers Screening by Multiplex ELISA Assay in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors.

Plasma Biomarkers Screening by Multiplex ELISA Assay in Patients with Advanced Non-Small Cell Lung Cancer Treated with Immune Checkpoint Inhibitors.

Journal: Cancers

Published: November 09, 2020

Baseline Hedgehog Pathway Activation and Increase of Plasma Wnt1 Protein Are Associated with Resistance to Immune Checkpoint Inhibitors in Advanced Non-Small-Cell Lung Cancer.

Baseline Hedgehog Pathway Activation and Increase of Plasma Wnt1 Protein Are Associated with Resistance to Immune Checkpoint Inhibitors in Advanced Non-Small-Cell Lung Cancer.

Journal: Cancers

Published: October 26, 2020

Functional assessment and phenotypic heterogeneity of SFTPA1 and SFTPA2 mutations in interstitial lung diseases and lung cancer.

Functional assessment and phenotypic heterogeneity of SFTPA1 and SFTPA2 mutations in interstitial lung diseases and lung cancer.

Journal: The European respiratory journal

Published: April 26, 2020

Sequential ctDNA whole-exome sequencing in advanced lung adenocarcinoma with initial durable tumor response on immune checkpoint inhibitor and late progression.

Sequential ctDNA whole-exome sequencing in advanced lung adenocarcinoma with initial durable tumor response on immune checkpoint inhibitor and late progression.

Journal: Journal for immunotherapy of cancer

Published: April 13, 2020

Positive plasma cotinine during platinum-based chemotherapy is associated with poor response rate in advanced non-small cell lung cancer patients.

Positive plasma cotinine during platinum-based chemotherapy is associated with poor response rate in advanced non-small cell lung cancer patients.

Journal: PloS one

Published: December 26, 2018

Role of antibiotic use, plasma citrulline and blood microbiome in advanced non-small cell lung cancer patients treated with nivolumab.

Role of antibiotic use, plasma citrulline and blood microbiome in advanced non-small cell lung cancer patients treated with nivolumab.

Journal: Journal for immunotherapy of cancer

Published: December 17, 2018

Predictive role of plasmatic biomarkers in advanced non-small cell lung cancer treated by nivolumab.

Predictive role of plasmatic biomarkers in advanced non-small cell lung cancer treated by nivolumab.

Journal: Oncoimmunology

Published: January 11, 2018

Showing 1-12 of 25

Last Updated: 09/26/2026